Literature DB >> 22888010

Electrospun tubular scaffolds: on the effectiveness of blending poly(ε-caprolactone) with poly(3-hydroxybutyrate-co-3-hydroxyvalerate).

Costantino Del Gaudio1, Lara Fioravanzo, Marcella Folin, Fabiana Marchi, Enrico Ercolani, Alessandra Bianco.   

Abstract

Tissue engineering can effectively contribute to the development of novel vascular prostheses aimed to overcome the well-known drawbacks of small-diameter grafts. To date, poly(ε-caprolactone) (PCL), a bioresorbable synthetic poly(α-hydroxyester), is considered one of the most promising materials for vascular tissue engineering. In this work, the potential advantage of intimate blending soft PCL and hard poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), a polymer of microbial origin, has been evaluated. Nonwoven mats and small-diameter tubular scaffolds of PCL, PHBV, and PCL/PHBV were fabricated by means of electrospinning technique. Mechanical properties and suture retention strength were investigated according to the international standard for cardiovascular implants. Biological tests demonstrated that both PCL-based scaffolds supported survival and growth of rat cerebral endothelial cells in a short time. The fiber alignment of the electrospun tubular scaffolds contributed to a more rapid and homogeneous cell colonization of the luminal surface.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22888010     DOI: 10.1002/jbm.b.32756

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  7 in total

1.  An engineered macroencapsulation membrane releasing FTY720 to precondition pancreatic islet transplantation.

Authors:  Daniel T Bowers; Claire E Olingy; Preeti Chhabra; Linda Langman; Parker H Merrill; Ritu S Linhart; Michael L Tanes; Dan Lin; Kenneth L Brayman; Edward A Botchwey
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2017-02-27       Impact factor: 3.368

2.  A novel porous scaffold fabrication technique for epithelial and endothelial tissue engineering.

Authors:  Kevin J McHugh; Sarah L Tao; Magali Saint-Geniez
Journal:  J Mater Sci Mater Med       Date:  2013-04-27       Impact factor: 3.896

Review 3.  Microalgae as Contributors to Produce Biopolymers.

Authors:  Rozita Madadi; Hamid Maljaee; Luísa S Serafim; Sónia P M Ventura
Journal:  Mar Drugs       Date:  2021-08-19       Impact factor: 5.118

4.  Aspirin-loaded electrospun poly(ε-caprolactone) tubular scaffolds: potential small-diameter vascular grafts for thrombosis prevention.

Authors:  Costantino Del Gaudio; Enrico Ercolani; Pierluca Galloni; Federico Santilli; Silvia Baiguera; Leonardo Polizzi; Alessandra Bianco
Journal:  J Mater Sci Mater Med       Date:  2012-11-08       Impact factor: 3.896

5.  Experimental orthotopic transplantation of a tissue-engineered oesophagus in rats.

Authors:  Sebastian Sjöqvist; Philipp Jungebluth; Mei Ling Lim; Johannes C Haag; Ylva Gustafsson; Greg Lemon; Silvia Baiguera; Miguel Angel Burguillos; Costantino Del Gaudio; Antonio Beltrán Rodríguez; Alexander Sotnichenko; Karolina Kublickiene; Henrik Ullman; Heike Kielstein; Peter Damberg; Alessandra Bianco; Rainer Heuchel; Ying Zhao; Domenico Ribatti; Cristián Ibarra; Bertrand Joseph; Doris A Taylor; Paolo Macchiarini
Journal:  Nat Commun       Date:  2014-04-15       Impact factor: 14.919

6.  Novel Poly(3-hydroxybutyrate-g-vinyl alcohol) Polyurethane Scaffold for Tissue Engineering.

Authors:  Adriana Pétriz Reyes; Ataúlfo Martínez Torres; Ma Del Pilar Carreón Castro; José Rogelio Rodríguez Talavera; Susana Vargas Muñoz; Víctor Manuel Velázquez Aguilar; Maykel González Torres
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379

7.  Vascular Endothelial Growth Factor Improves Physico-Mechanical Properties and Enhances Endothelialization of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/Poly(ε-caprolactone) Small-Diameter Vascular Grafts In vivo.

Authors:  Larisa V Antonova; Victoria V Sevostyanova; Anton G Kutikhin; Andrey V Mironov; Evgeniya O Krivkina; Amin R Shabaev; Vera G Matveeva; Elena A Velikanova; Evgeniya A Sergeeva; Andrey Y Burago; Georgiy Y Vasyukov; Tatiana V Glushkova; Yuliya A Kudryavtseva; Olga L Barbarash; Leonid S Barbarash
Journal:  Front Pharmacol       Date:  2016-07-29       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.